Prices may be delayed and are for informational purposes only - not investment advice.
Revenue and net income (annual)
RevenueNet Income
2021
₺37.83B
₺13.47B
2022
₺101.99B
₺61.54B
2023
₺135.39B
₺72.26B
2024
₺141.05B
₺45.52B
2025
₺230.27B
₺67.44B
Valuation (computed from filings)
Valuation period
LTM · 2026/9 · 2026-09-30
Earnings per share
₺2.55
P/E
5.3x
Book value / share
₺18.29
P/B
0.7x
Revenue / share
₺12.06
P/S
1.1x
Return on equity
14.0%
Operating margin
4.5%
Net margin
21.2%
Liabilities / equity
10.6x
Diluted shares
25.00B
Price-based ratios always use the current price, not the price at the end of the period. These ratios divide the lines in the statements below by the current price; both inputs of every value are visible on this page. The P/E on the overview comes from the same calculation. P/E and P/S are left blank for loss-making companies or where revenue is not reported. Not investment advice.
Taken from the financial statements the company files with Turkey's Public Disclosure Platform (KAP), in Turkish lira. Non-financial companies restate prior periods for inflation (IAS 29) into the purchasing power of their latest report, so every column is in the same, current lira - older years therefore read higher than the figures originally published. The "LTM" column is the last fiscal year plus the current year to date, minus the same period a year earlier. Not investment advice. This company reports on a bank/financial-institution template: the income statement is built on an interest spread rather than on sales, and the balance sheet has no current/non-current split. The "Total revenue (net)" line is net interest income plus non-interest income; providers define revenue differently for lenders, so this figure may not match the "revenue" shown elsewhere. This table uses standalone financial statements. Consolidated reports are not directly comparable. Insurers’ revenue is net earned premiums.